Nypozi (filgrastim)

pCPA File Number: 21891

Negotiation Status:

Concluded with an LOI

Indication(s):

Prevention or treatment of neutropenia in various indications

Sponsor/Manufacturer:

Tanvex BioPharma USA, Inc.

CADTH Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2022-12-15

Negotiation Process Concluded:

2023-03-10